Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
Size: 5 mg
No published analyses yet.
Research, properties and limitations
AI can make mistakes
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 250 mcg once daily, subcutaneous | Starting dose |
| Extended regimen | 500 mcg/day (125–250 mcg AM + PM) | Increase if needed |
| Upper bound (4–6 week cycle) | up to 800 mcg/day | Maximum in this schedule |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| No serious toxicity reported in the specific Xu (2020) tests | Mice, rats, rabbits, dogs | Single dose: no test-related effects; repeated doses (dogs): well tolerated, no serious toxicity observed in those tests | [2] |
| Lower serum creatinine | Dogs, repeated doses | Seen at 2 mg/kg but not at lower doses; the animals recovered spontaneously after two weeks of withdrawal | [2] |
| Local irritation at the injection site | Animal local tolerance test |
FAQ
Find answers to questions about BPC-157 and related materials.
It is a 15-amino-acid peptide whose sequence copies a piece of a protective protein from human gastric juice — hence the name Body Protection Compound. In preclinical models it supports tissue healing and new blood-vessel growth, which made it the central tool of recovery research: tendons, ligaments, muscle, the gut lining.
Source / documentationIn cell and animal models, yes: the peptide sped up tendon-fibroblast migration and new vessel growth toward the damage. But honestly about the limits: there are no large human trials and the evidence base is almost entirely preclinical, so an effect in people is unproven. A full review of the data is in the BPC-157 monograph in our wiki.
Source / documentationThe powder is dissolved with bacteriostatic water and injected under the skin, often closer to the area of interest. Described regimens start at 250 mcg a day; the extended regimen is 500 mcg a day split between morning and evening. Exact schedules are in the dosing guide on this page.
Source / documentationThey are different, complementary mechanisms: BPC-157 works mainly locally, near the area of interest, supporting vessels and cell migration, while TB-500 acts systemically through the actin skeleton of cells throughout the body. That is why they are often combined; we also carry a ready blend of both peptides in one vial.
Source / documentationThe peptide is unusually tough: in models it survived even the acid environment of the stomach, where most peptides are destroyed. Our product, however, is a lyophilised powder, and the described regimens are for subcutaneous injection; we do not sell BPC-157 tablets.
Source / documentationAn honest list for humans cannot be compiled: no clinical studies in people have been run. In preclinical models the peptide was well tolerated, but that is no substitute for human data; no dedicated receptor for it has been found yet either. Details are in the BPC-157 monograph in our wiki.
Source / documentationTissue healing takes weeks, not days: described regimens run for several weeks of daily injections, and studies began assessing effects no earlier than 2–4 weeks in. The exact duration depends on the task; schedules are in the dosing guide on this page.
Source / documentationKeep the dry powder in a dry, dark place at a low temperature; once dissolved, store it in the refrigerator and do not freeze it again. Details are in the BPC-157 guide on this page.
Source / documentationYou can buy BPC-157 right on this page of our store: choose a pack size; current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentation| Described as mild |
| [2] |
Share your experience
No reviews yet. Tell others what you think of this product.
BPC-157 is a 15-amino-acid peptide whose sequence copies a fragment of a protective protein from human gastric juice (hence the name: Body Protection Compound). Its structure makes it unusually tough: it survives even the acid environment of the stomach, where most peptides are destroyed.
What it does in models: it supports healing and the growth of new blood vessels (via the VEGFR2 receptor and the Akt/eNOS pathway), and in tendon fibroblasts it speeds up the migration of the very cells that "patch" damage. That is why BPC-157 has become the central tool of recovery research: tendons, ligaments, muscle, the gut lining.
Honestly about the limits: no dedicated receptor has been found for this peptide yet, and the evidence base is almost entirely preclinical (cells and animals); there are no large human trials. Details and sources are in the BPC-157 monograph.
How it is used: the dry powder is dissolved with bacteriostatic water and injected under the skin, often closer to the area of interest. Described regimens start at 250 mcg a day; the extended regimen is 500 mcg split between morning and evening. Schedules are in the dosing guide; its most common partner is TB-500 (there is also a ready blend); the full line is in the healing and regeneration category.
Every batch is purity-tested by HPLC, and the certificate of analysis (COA) for your exact batch is in our COA archive. Keep the dry powder in a dry, dark place at a low temperature, and the dissolved solution in the refrigerator.